期刊文献+

Fas-670 A/G polymorphism predicts prognosis of hepatocellular carcinoma after curative resection in Chinese Han population

下载PDF
导出
摘要 Background:Apoptosis,also called programmed cell death,is a genetically controlled process against hyperproliferation and malignancy.The Fas-Fas ligand(FasL)system is considered a major pathway for apoptosis in cells and tissues.Thus,this study aimed to investigate whether single nucleotide polymor-phisms(SNPs)in Fas and FasL gene may have effects on the recurrence and survival of patients with hepatocellular carcinoma(HCC)after curative hepatectomy.Methods:We investigated the relationship between Fas rs1800682,rs2234767 and FasL rs763110 poly-morphisms and recurrence-free survival(RFS)as well as overall survival(OS)in 117 Chinese Han patients with HCC who underwent hepatectomy.Results:In Kaplan-Meier survival analysis,only Fas rs1800682(-670 A/G)was associated with RFS and OS.Compared with AA genotype,the AG/GG genotype was significantly associated with better RFS(P=0.008)and OS(P=0.020).Moreover,multivariate Cox regression analysis showed that Fas rs1800682 remained as a significant independent predictor of RFS for HCC patients with hepatectomy[AG/GG vs.AA:adjusted hazard ratio=0.464,95%confidence interval:0.275-0.782,P=0.004],but was not an independent predictor of OS(P=0.395).Conclusions:This study demonstrated that Fas-670 G allele may play a protective role in the recurrence and survival of HCC patients with hepatectomy.Furthermore,Fas rs1800682 polymorphism might be a promising biomarker for HCC patients after hepatectomy.
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2022年第1期33-40,共8页 国际肝胆胰疾病杂志(英文版)
基金 supported by grants from the Sichuan Sci-ence and Technology Program(2019YFS0370) National Univer-sity Student Innovation and Entrepreneurship Training Programs(C2019104465).
  • 相关文献

参考文献2

二级参考文献30

  • 1Li-NingXu Sheng-QuanZou Jian-MingWang.Action and mechanism of Fas and Fas ligand in immune escape of gallbladder carcinoma[J].World Journal of Gastroenterology,2005,11(24):3719-3723. 被引量:6
  • 2Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917. 被引量:1
  • 3Jemal A, Bray F, Center MM, FerJay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90. 被引量:1
  • 4Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008; 83: 584-94. 被引量:1
  • 5Cotter TG. Apoptosis and cancer: the genesis of a re-search field. Nat Rev Cancer 2009; 9: 501-7. 被引量:1
  • 6Vermeulen K, Van Bockstaele DR, Berneman ZN. Ap-optosis: mechanisms and relevance in cancer. Ann He-mato12005; 84: 627-39. 被引量:1
  • 7Lowe SW, Lin A W. Apoptosis in cancer. Carcinogenesis 2000; 21: 485-95. 被引量:1
  • 8Singhal S, Vachani A, Antin-Ozerkis D, Kaiser LR, AI-belda SM. Prognostic implications of cell cycle, apopto-sis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res 2005; 11: 3974-86. 被引量:1
  • 9Nuckel H, Frey UH, Bau M, Sellmann L, Stanelle J, Durig J, et al. Association of a novel regulatory poly-morphism (-938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia. Blood 2007; 109: 290-7. 被引量:1
  • 10Bachmann HS, Otterbach F, Callies R, Nuckel H, Bau M, Schmid KW, et al. The AA genotype of the regulatory BCL2 promoter polymorphism ( 938C>A) is associated with a favorable outcome in lymph node negative inva-sive breast cancer patients. Clin Cancer Res 2007; 13: 5790-7. 被引量:1

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部